Artificial Intelligence in Reproductive Life-Course Planning

Abstract

Artificial Intelligence (AI) is transforming reproductive life-course planning by enhancing decision support, risk stratification, and personalized patient care across fertility, contraception, pregnancy, and menopause. This article reviews the latest clinical applications, mechanisms, and evidence supporting AI integration into reproductive health, addressing epidemiology, pathophysiology, risk factors, diagnosis, management, recent advances, and guideline recommendations. Insights focus on practical implications for clinicians, with an emphasis on emerging therapies, risk-benefit considerations, and future directions for optimizing reproductive trajectories through intelligent systems.

Introduction

Reproductive life-course planning encompasses a continuum from fertility intentions to menopause, involving a complex interplay of biological, psychological, and social determinants. With increasing demand for personalized and predictive healthcare, AI-driven solutions offer unprecedented opportunities to optimize reproductive outcomes. AI algorithms, including machine learning (ML) and deep learning models, are now integrated into diverse reproductive health domains, from gamete selection in assisted reproduction to contraception counseling and menopause management. This review synthesizes multidisciplinary evidence on the clinical utility, mechanisms, and future prospects of AI in reproductive life-course planning, providing healthcare professionals with a comprehensive resource for evidence-based practice.

Epidemiology / Disease Burden

Globally, subfertility affects an estimated 15% of couples, while unintended pregnancies comprise nearly 50% of all pregnancies. Reproductive health disparities persist across populations, influenced by socioeconomic factors, access to care, and underlying conditions such as polycystic ovary syndrome (PCOS) and endometriosis. The increasing prevalence of delayed childbearing, chronic conditions, and lifestyle-related risks further complicates reproductive planning. AI tools are poised to address these challenges by identifying at-risk individuals, predicting outcomes, and enabling timely interventions, thereby reducing disease burden and improving reproductive health equity.

Pathophysiology

AI enhances understanding of reproductive pathophysiology by integrating multi-omic, imaging, and clinical datasets. In infertility, machine learning models analyze ovarian reserve markers, sperm quality, and endometrial receptivity, facilitating mechanistic insights into subfertility and embryo implantation failure. AI-driven analysis of hormonal fluctuations, ovulatory patterns, and menstrual irregularities enables early identification of endocrine disorders such as PCOS and hypothalamic amenorrhea. Furthermore, AI-based image analysis assists in the detection of structural uterine and adnexal pathologies, refining diagnostic pathways and informing individualized management strategies.

Risk Factors

Established risk factors for adverse reproductive outcomes include advanced maternal age, obesity, smoking, chronic diseases (e.g., diabetes, hypertension), and genetic predisposition. AI algorithms leverage electronic health records (EHRs) and population health data to stratify individuals by cumulative reproductive risks. Predictive models estimate the likelihood of infertility, pregnancy complications (e.g., preeclampsia, gestational diabetes), and early menopause, enabling proactive counseling and interventions. By continuously learning from real-world data, AI supports dynamic risk assessment tailored to evolving patient profiles.

Clinical Features

Reproductive life-course disorders present with diverse clinical features: menstrual irregularities, subfertility, recurrent pregnancy loss, and menopausal symptoms. AI-powered symptom trackers and mobile health applications capture longitudinal patient-reported data, facilitating early recognition of deviations from normative reproductive trajectories. Natural language processing (NLP) and wearable biosensors further augment clinical feature extraction, supporting timely referral and multidisciplinary collaboration in complex reproductive cases.

Diagnosis

Diagnostic precision in reproductive health is bolstered by AI technologies capable of integrating heterogeneous data types. Deep learning models interpret ultrasound and MRI images for detection of uterine fibroids, ovarian cysts, and endometrial pathology. Automated analysis of hormonal profiles and genetic panels enhances diagnostic accuracy for conditions such as PCOS, premature ovarian insufficiency, and inherited thrombophilias. AI-based semen analysis platforms provide objective, reproducible assessments of sperm morphology and motility, reducing inter-observer variability and expediting infertility workups.

Treatment & Management

Personalized treatment algorithms, informed by AI, are reshaping reproductive management. In assisted reproductive technology (ART), AI optimizes ovarian stimulation protocols, embryo selection, and timing of embryo transfer, improving implantation and live birth rates. AI-guided decision support tools assist clinicians in selecting appropriate contraceptive methods based on individual risk profiles and preferences. In menopause management, AI models synthesize symptom burden, comorbidities, and pharmacogenomic data to tailor hormone therapy recommendations, balancing efficacy and safety.

Recent Advances / Emerging Therapies

Recent innovations include AI-enabled non-invasive embryo selection using time-lapse imaging, predictive modeling of ovarian response, and integration of wearable sensor data for menstrual and ovulatory tracking. AI-driven chatbots and virtual assistants provide real-time reproductive counseling and adherence support. Emerging therapies leverage AI to identify novel biomarkers, predict response to fertility preservation interventions, and design individualized protocols for oncofertility patients. Federated learning approaches preserve data privacy while enabling multicenter collaboration and model generalizability.

Guideline Recommendations

Professional societies increasingly acknowledge the role of AI in reproductive health, emphasizing integration with clinical judgment and patient-centered care. Guidelines advocate for transparent validation of AI models, continuous outcome monitoring, and multidisciplinary oversight. Clinicians are encouraged to engage in shared decision-making, incorporating AI-derived insights alongside evidence-based recommendations and patient preferences. Ongoing education on AI literacy is essential to ensure ethical, equitable, and effective implementation across reproductive care settings.

Conclusion

AI-driven tools are redefining reproductive life-course planning by augmenting clinical decision-making, personalizing risk assessment, and improving outcomes across fertility, contraception, pregnancy, and menopause. As evidence continues to evolve, clinicians must remain vigilant in appraising AI technologies, ensuring alignment with best practice and patient values. The future of reproductive medicine lies in synergistic integration of AI, multidisciplinary expertise, and compassionate care, fostering optimal reproductive trajectories for diverse populations.